Optimizing short-term antibiotic treatment in patients with acute cholangitis: study protocol for an open-label randomized controlled trial (the BOLT-P3 trial)

This phase 3 trial aims to determine the non-inferiority of short-course therapy over standard-course therapy. Shortening the duration of antibiotic administration may mitigate the emergence of resistant bacteria, adverse events, and reduce hospital stay length and healthcare costs. https://jrct.niph.go.jp/re/reports/detail/73862 TRIAL REGISTRATION: This study was registered at the Japan Registry of Clinical Trials under registry number jRCT1031230709. Registered on 14 March 2024, https://jrct.niph.go.jp/re/reports/detail/73862.

Authors

Institutions

Publication Details

Journal
Trials
Published
2025-09-01
DOI
https://doi.org/10.1186/s13063-025-09077-1
Primary Topic
Gallbladder and Bile Duct Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimizing short-term antibiotic treatment in patients with acute cholangitis: study protocol for an open-label randomized controlled trial (the BOLT-P3 trial)

Aya Kawanishi, Hiroshi Takihara, Yoshinori Imamura, Tomoaki Fujikawa et al.
Trials
Gallbladder and Bile Duct Disorders
article

Optimizing short-term antibiotic treatment in patients with acute cholangitis: study protocol for an open-label randomized controlled trial (the BOLT-P3 trial)

Aya Kawanishi, Hiroshi Takihara, Yoshinori Imamura, Tomoaki Fujikawa, Kyohei Maejima, Kazuya Koizumi, Ryuhei Jinushi, Satoru Noda, Jun Kubota, Taiji Koyama, Karen Kimura, Ayumu Sugitani, Shomei Ryozawa, Makomo Makazu, Sakue Masuda, Ryuichi Yamamoto
article en

Abstract

This phase 3 trial aims to determine the non-inferiority of short-course therapy over standard-course therapy. Shortening the duration of antibiotic administration may mitigate the emergence of resistant bacteria, adverse events, and reduce hospital stay length and healthcare costs. https://jrct.niph.go.jp/re/reports/detail/73862 TRIAL REGISTRATION: This study was registered at the Japan Registry of Clinical Trials under registry number jRCT1031230709. Registered on 14 March 2024, https://jrct.niph.go.jp/re/reports/detail/73862.

TrialsVol. 26(1)
Tokai University (JP), Shonan Institute of Technology (JP), Fujisawa City Hospital (JP), Sapporo Higashi Tokushukai Hospital (JP), San-ikukai Hospital (JP), Fukuoka Tokushukai Hospital (JP), University of Fukui Hospital (JP), Chiba-Nishi General Hospital (JP), Uji Hospital (JP), Saitama International Medical Center (JP), Shonan Kamakura General Hospital (JP), Kobe University (JP), Saitama Medical University (JP)
Japan Research Foundation for Clinical Pharmacology
Openalex Percentile: Top 66%
Gallbladder and Bile Duct Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.